Cargando…

Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy

BACKGROUND: Glucose-insulin-potassium (GIK) may improve cardiovascular performance after coronary artery bypass graft surgery (CABG). Our study investigated whether an infusion of GIK during elective CABG surgery in type II diabetic patient improved left ventricular performance. METHODS: We measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Seied-Hosseini, Seied Mostafa, Pourmoghadas, Ali, Aghadavoudi, Omid, Amini, Masoud, Mirmohammad-Sadeghi, Mohsen, Golabchi, Allahyar, Hedayatpour, Behnood, Haratian, Elham, Ghaem-Maghami, Narges, Khanoom Sharegh, Laleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347817/
https://www.ncbi.nlm.nih.gov/pubmed/22577416
_version_ 1782232328153595904
author Seied-Hosseini, Seied Mostafa
Pourmoghadas, Ali
Aghadavoudi, Omid
Amini, Masoud
Mirmohammad-Sadeghi, Mohsen
Golabchi, Allahyar
Hedayatpour, Behnood
Haratian, Elham
Ghaem-Maghami, Narges
Khanoom Sharegh, Laleh
author_facet Seied-Hosseini, Seied Mostafa
Pourmoghadas, Ali
Aghadavoudi, Omid
Amini, Masoud
Mirmohammad-Sadeghi, Mohsen
Golabchi, Allahyar
Hedayatpour, Behnood
Haratian, Elham
Ghaem-Maghami, Narges
Khanoom Sharegh, Laleh
author_sort Seied-Hosseini, Seied Mostafa
collection PubMed
description BACKGROUND: Glucose-insulin-potassium (GIK) may improve cardiovascular performance after coronary artery bypass graft surgery (CABG). Our study investigated whether an infusion of GIK during elective CABG surgery in type II diabetic patient improved left ventricular performance. METHODS: We measured left ventricular ejection fraction and troponin (Tn), a myofibrillar structural protein. In this research, after ethics committee approval, 50 patients with type 2 diabetes mellitus (DM) were enrolled into a randomized simple sampling, prospective, double-blind clinical trial study. In the case group, 500 cc dextrose water 5% plus 80 IU regular insulin and 40 mEq KCL were infused at the rate of 30 cc/hr. Patients in control group received 5% dextrose solution at the rate of 30cc/hr. Venous blood samples were taken before induction of anesthesia, after removal of the aortic clamp and before discharging from hospital. The Mann-Whitney-test was used to test for differences in troponin concentration between the groups. Fisher's exact test was used to determine whether there was a difference in the proportion of patients with a low ejection fraction (<45%) in the case group compared with that in the control group. Changes in potassium and glucose concentrations over time within the groups were examined by ANOVA and paired t-tests. P < 0.05 was regarded as significant level for all tests. RESULTS: In this study, 50 patients with type 2 DM were evaluated in case and control groups. The mean age ± SD in the case group was 57.7 ± 9.9 years and in the other group was 61.2 ± 8.4 years. The groups were well-matched for age, sex and number of bypass grafts. Randomization did not give an equal distribution of male and female patients. There wasn't any significant difference in ejection fraction between the case and control groups before and after CABG (P > 0.05). Troponin concentration in the case group was 3.3 ± 5.0 and in the control group was 3.9 ± 5.1. There was no significant difference in Tn between the two groups before and after CABG (P > 0.05). There was not any significant difference in hospitalization time between the two groups. CONCLUSION: The results suggested that GIK can't improve left ventricular performance in routine CABG surgery.
format Online
Article
Text
id pubmed-3347817
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-33478172012-05-10 Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy Seied-Hosseini, Seied Mostafa Pourmoghadas, Ali Aghadavoudi, Omid Amini, Masoud Mirmohammad-Sadeghi, Mohsen Golabchi, Allahyar Hedayatpour, Behnood Haratian, Elham Ghaem-Maghami, Narges Khanoom Sharegh, Laleh ARYA Atheroscler Original Article BACKGROUND: Glucose-insulin-potassium (GIK) may improve cardiovascular performance after coronary artery bypass graft surgery (CABG). Our study investigated whether an infusion of GIK during elective CABG surgery in type II diabetic patient improved left ventricular performance. METHODS: We measured left ventricular ejection fraction and troponin (Tn), a myofibrillar structural protein. In this research, after ethics committee approval, 50 patients with type 2 diabetes mellitus (DM) were enrolled into a randomized simple sampling, prospective, double-blind clinical trial study. In the case group, 500 cc dextrose water 5% plus 80 IU regular insulin and 40 mEq KCL were infused at the rate of 30 cc/hr. Patients in control group received 5% dextrose solution at the rate of 30cc/hr. Venous blood samples were taken before induction of anesthesia, after removal of the aortic clamp and before discharging from hospital. The Mann-Whitney-test was used to test for differences in troponin concentration between the groups. Fisher's exact test was used to determine whether there was a difference in the proportion of patients with a low ejection fraction (<45%) in the case group compared with that in the control group. Changes in potassium and glucose concentrations over time within the groups were examined by ANOVA and paired t-tests. P < 0.05 was regarded as significant level for all tests. RESULTS: In this study, 50 patients with type 2 DM were evaluated in case and control groups. The mean age ± SD in the case group was 57.7 ± 9.9 years and in the other group was 61.2 ± 8.4 years. The groups were well-matched for age, sex and number of bypass grafts. Randomization did not give an equal distribution of male and female patients. There wasn't any significant difference in ejection fraction between the case and control groups before and after CABG (P > 0.05). Troponin concentration in the case group was 3.3 ± 5.0 and in the control group was 3.9 ± 5.1. There was no significant difference in Tn between the two groups before and after CABG (P > 0.05). There was not any significant difference in hospitalization time between the two groups. CONCLUSION: The results suggested that GIK can't improve left ventricular performance in routine CABG surgery. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2010 /pmc/articles/PMC3347817/ /pubmed/22577416 Text en © 2010 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Seied-Hosseini, Seied Mostafa
Pourmoghadas, Ali
Aghadavoudi, Omid
Amini, Masoud
Mirmohammad-Sadeghi, Mohsen
Golabchi, Allahyar
Hedayatpour, Behnood
Haratian, Elham
Ghaem-Maghami, Narges
Khanoom Sharegh, Laleh
Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy
title Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy
title_full Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy
title_fullStr Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy
title_full_unstemmed Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy
title_short Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy
title_sort efficacy of glucose-insulin-potassium infusion on left ventricular performance in type ii diabetic patients undergoing elective coronary artery bypass graft.dy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347817/
https://www.ncbi.nlm.nih.gov/pubmed/22577416
work_keys_str_mv AT seiedhosseiniseiedmostafa efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT pourmoghadasali efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT aghadavoudiomid efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT aminimasoud efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT mirmohammadsadeghimohsen efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT golabchiallahyar efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT hedayatpourbehnood efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT haratianelham efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT ghaemmaghaminarges efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy
AT khanoomshareghlaleh efficacyofglucoseinsulinpotassiuminfusiononleftventricularperformanceintypeiidiabeticpatientsundergoingelectivecoronaryarterybypassgraftdy